Open Access

Complex interplays: Asthma management and maternal‑fetal outcomes in pregnancy (Review)

  • Authors:
    • Vasiliki Epameinondas Georgakopoulou
    • Chrysoula Taskou
    • Demetrios A. Spandidos
    • Athina Diamanti
  • View Affiliations

  • Published online on: October 11, 2024     https://doi.org/10.3892/etm.2024.12744
  • Article Number: 454
  • Copyright: © Georgakopoulou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Asthma, a common chronic respiratory condition, poses unique challenges in pregnancy, impacting both maternal and fetal health. Of note, 8‑13% of pregnant women suffer from asthma, a condition that can worsen, stabilize, or improve during pregnancy. These fluctuations necessitate a nuanced management strategy to ensure the health of both the mother and fetus. Adverse outcomes, such as preeclampsia, gestational diabetes and increased cesarean delivery rates are associated with poorly controlled asthma. From a fetal perspective, the risks include preterm birth and a low birth weight. Physiological changes in pregnancy, such as an increased tidal volume and altered drug metabolism due to increased blood volume, complicate the management of asthma. The safety of asthma medications during pregnancy remains a significant concern, with ongoing research into their teratogenic effects. Recent advancements in treatment include the development of biologics and the increased use of personalized medicine, integrating pharmacogenomics and immunological profiling to tailor treatments to individual needs. Digital health tools have also emerged, enabling improved patient monitoring and management. The present review highlights the complex interplay between asthma management and pregnancy outcomes, advocating for comprehensive care approaches that consider the dynamic physiological changes during pregnancy. It underscores the need for ongoing research into the safety of medication and innovative therapeutic strategies to improve health outcomes for pregnant women with asthma and their babies.
View Figures
View References

Related Articles

Journal Cover

December-2024
Volume 28 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Georgakopoulou VE, Taskou C, Spandidos DA and Diamanti A: Complex interplays: Asthma management and maternal‑fetal outcomes in pregnancy (Review). Exp Ther Med 28: 454, 2024.
APA
Georgakopoulou, V.E., Taskou, C., Spandidos, D.A., & Diamanti, A. (2024). Complex interplays: Asthma management and maternal‑fetal outcomes in pregnancy (Review). Experimental and Therapeutic Medicine, 28, 454. https://doi.org/10.3892/etm.2024.12744
MLA
Georgakopoulou, V. E., Taskou, C., Spandidos, D. A., Diamanti, A."Complex interplays: Asthma management and maternal‑fetal outcomes in pregnancy (Review)". Experimental and Therapeutic Medicine 28.6 (2024): 454.
Chicago
Georgakopoulou, V. E., Taskou, C., Spandidos, D. A., Diamanti, A."Complex interplays: Asthma management and maternal‑fetal outcomes in pregnancy (Review)". Experimental and Therapeutic Medicine 28, no. 6 (2024): 454. https://doi.org/10.3892/etm.2024.12744